Physician profile
Sharon Angelo
NPI 1811991458
$4,463.93
in general payments reported to CMS, 2019-2025
16 companies · $676 in 2025
The $676 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $486 · 2021: $799 · 2022: $464 · 2023: $632 · 2024: $946 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,253.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,652.24 | 2021-2025 | Qulipta, Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $831.34 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $659.88 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Arbor Pharmaceuticals, INC. | $435.24 | 2019-2021 | |
| Antares Pharma, INC. | $370.79 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Biohaven Pharmaceutical Holding Company Ltd. | $131.83 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $128.94 | 2019-2022 | |
| Halozyme INC | $75.00 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.09 | 2019-2021 | |
| Ibsa Pharma INC. | $35.25 | 2024 | Licart, Tirosint |
| Aytu Biopharma, INC. | $30.00 | 2020 | |
| Azurity Pharmaceuticals, INC. | $15.37 | 2025 | Azmiro |
| Janssen Pharmaceuticals, INC | $15.00 | 2021 | |
| Pfizer INC. | $13.70 | 2024 | |
| Exact Sciences Corporation | $13.70 | 2023 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $13.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Angelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.